Postpartum Engagement in HIV Care: An Important Predictor of Long-term Retention in Care and Viral Suppression

Clinical Infectious Diseases

Volumn 61, Issue 12, 2015, Pages 1880-1887

  Adams, Joëlla W ^a   Brady, Kathleen A ^a,b   Michael, Yvonne L ^c   Yehia, Baligh R ^b,d   Momplaisir, Florence M ^e  

^a PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DREXEL UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

HIV care continuum; HIV AIDS; maternal health; postpartum; retention in care

Indexed keywords

ANTIVIRUS AGENT;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PRENATAL CARE; PRESCRIPTION; PRIORITY JOURNAL; PUERPERIUM; RETROSPECTIVE STUDY; VIRAL SUPPRESSION; VIRUS INHIBITION; VIRUS LOAD; HIV INFECTIONS; MEDICATION COMPLIANCE; NEWBORN; PENNSYLVANIA; PREGNANCY; PROGNOSIS; YOUNG ADULT;

ADULT; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; MEDICATION ADHERENCE; PHILADELPHIA; POSTPARTUM PERIOD; PREGNANCY; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84961619776     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ678     Document Type: Conference Paper

References (41)

1. Cheever LW. Engaging HIV-infected patients in care: their lives depend on it. Clin Infect Dis 2007; 44:1500-2.
2. Eldred L, Malitz F. Introduction [to the supplemental issue on the HRSA SPNS outreach initiative]. AIDS Patient Care STDS 2007; 21 (suppl 1):S1-2.
3. Gardner EM, McLees MP, Steiner JF, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011; 52:793-800.
4. Wilson TE, Ickovics JR, Fernandez MI, et al. Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states. Am J Obstet Gynecol 2001; 184:1235-40.
5. Bardeguez AD, Lindsey JC, Shannon M, et al. Adherence to antiretrovirals among US women during and after pregnancy. J Acquir Immune Defic Syndr 2008; 48:408.
6. Eberhart MG, Yehia BR, Hillier A, et al. Behind the cascade: analyzing spatial patterns along the HIV care continuum. J Acquir Immune Defic Syndr 2013; 64(suppl 1):S42-51.
7. Vitalis D. Factors affecting antiretroviral therapy adherence among HIV-positive pregnant and postpartum women: an adapted systematic review. Int J STD AIDS 2013; 24:427-32.
8. Onen NF, Nurutdinova D, Sungkanuparph S, et al. Effect of postpartum HIV treatment discontinuation on long-term maternal outcome. J Int Assoc Provid AIDS Care 2008; 7:245-51.
9. Aebi-Popp K, Kouyos R, Bertisch B, et al. Loss to follow-up of HIV-infected women after delivery: The Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort Study. J Int AIDS Soc 2014; 17(suppl 3):S1953.
10. Watson-Jones D, Balira R, Ross DA, et al. Missed opportunities: poor linkage into ongoing care for HIV-positive pregnant women in Mwanza, Tanzania. PLoS One 2012; 7:e40091.
11. Phillips T, Thebus E, Bekker LG, et al. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: A cohort study. J Int AIDS Soc 2014; 17:19242.
12. Sha BE, Tierney C, Cohn SE, et al. Postpartumviral load rebound inHIV-1 infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150. HIV Clin Trials 2011; 12:9-23.
13. Mocroft A, Ruiz L, Reiss P, et al. Virological rebound after suppression on highly active antiretroviral therapy. AIDS 2003; 17:1741-51.
14. Ellis GM, Huang S, Hitti J, et al. Selection of HIV resistance associated with antiretroviral therapy initiated due to pregnancy and suspended postpartum. J Acquir Immune Defic Syndr 2011; 58:241-7.
15. Watts DH, Lambert J, Stiehm ER, et al. Progression of HIV disease among women following delivery. J Acquir Immune Defic Syndr 2003; 33:585-93.
16. Chilongozi D,Wang L, Brown L, et al. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania. Pediatr Infect Dis J 2008; 27:808.
17. Kuhn L, Kasonde P, Sinkala M, et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis 2005; 41:1654-61.
18. Zaba B, Whitworth J, Marston M, et al. HIV and mortality of mothers and children: evidence from cohort studies in Uganda, Tanzania, and Malawi. Epidemiology 2005; 16:275-80.
19. Anderson J. A guide to the clinical care of women with HIV. Rockville, MD: US Department of Health and Human Services, Health Resources and Services Administration, HIV/AIDS Bureau, 2005.
20. Centers for Disease Control and Prevention. Enhanced perinatal surveillance-15 areas, 2005-2008. HIV Surveill Suppl Rep 2011; 16. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/. Accessed 15 January 2015.
21. AIDS Activities Coordinating Office. Surveillance report 2013: HIV/AIDS in Philadelphia. Available at: http://www.phila.gov/health/pdfs/AACO%202013%20Surveillance%20Report%20Final-dt.pdf. Accessed 24 December 2014.
22. US Department of Health and Human Services. HIV/AIDS care continuum. Available at: https://www.aids.gov/federal-resources/policies/carecontinuum/. Accessed 15 January 2015.
23. HIV Medicine Association. Tools for monitoring HIV Care: HIV clinical quality measures. Available at: http://www.hivma.org/uploadedFiles/HIVMA/Policy-and-Advocacy/Policy-Priorities/Healthcare-Reform-Implementation/Resources/Tools-for-Monitoring-Issue-Brief-final. pdf. Accessed 15 January 2015.
24. Whitmore SK, Taylor AW, Espinoza L, et al. Correlates of mother-tochild transmission of HIV in the United States and Puerto Rico. Pediatrics 2012; 129:e74-81.
25. Stringer M. Issues in determining and measuring adequacy of prenatal care. J Perinatol 1997; 18:68-73.
26. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents-2007. Available at: http://aidsinfo.nih.gov/contentfiles/adultandadolescentgl000721.pdf. Accessed 15 January 2015.
27. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents-2009. Available at: http://aidsinfo.nih.gov/contentfiles/adultandadolescentgl001561.pdf. Accessed 15 January 2015.
28. Boehme AK, Davies SL, Moneyham L. A qualitative study on factors impacting HIV care adherence among postpartum HIV-infected women in the rural southeastern USA. AIDS Care 2014; 26:574-81.
29. Stewart RD,Wells CE, Roberts SW, et al. Benefit of interpregnancy HIV viral load suppression on subsequent maternal and infant outcomes. Am J Obstet Gynecol 2014; 211:297.e1-6.
30. Cavallo IK, Kakehasi FM, Andrade BA, et al. Predictors of postpartum viral load rebound in a cohort of HIV-infected Brazilian women. Int J Gynaecol Obstet 2010; 108:111-4.
31. Rana AI, Gillani FS, Flanigan TP, et al. Follow-up care among HIVinfected pregnant women in Mississippi. J Womens Health 2010; 19:1863-7.
32. Momplaisir FM, Brady KA, Fekete T, et al. Time of HIV diagnosis and engagement in prenatal care impact virologic outcomes of pregnant women with HIV. PLoS One 2015; 10:e0132262.
33. Geng EH, Hare CB, Kathn JO, et al. The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/uL in a public health setting. Clin Infect Dis 2012; 55:1690-7.
34. Tedaldi EM, Richardson JT, Debes R, et al. Retention in care within 1 year of initiation HIV care visit in a multisite US cohort: who's in and who's out? J Int Assoc Provid AIDS Care 2014; 13:232-41.
35. Rebeiro P, Althoff KN, Buchacz K, et al. Retention among North American HIV-infected persons in clinical care, 2000-2008. J Acquir Immune Defic Syndr 2013; 62:356-62.
36. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data-United States and 6 dependent areas-2012. HIV Surveill Suppl Rep 2014; 19. Available at: http://www.cdc.gov/hiv/library/reports/surveillance/. Accessed 7 January 2015.
37. Gray KM, Cohen SM, Hu X, et al. Jurisdiction level differences in HIV diagnosis, retention in care, and viral suppression in the United States. J Acquir Immune Defic Syndr 2014; 65:129-32.
38. Mugavero MJ, Davila JA, Nevin CR, et al. From access to engagement: measuring retention in outpatient HIV clinical care. AIDS Patient Care STDS 2010; 24:607-13.
39. Yehia BR, Fleishman JA, Metlay JP, et al. Comparing different measures of retention in outpatient HIV care. AIDS 2012; 26:1131-9.
40. El-Khatib Z, Ekstrom AM, Coovadia A, et al. Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa: A prospective cohort study. BMC Public Health 2011; 11:88.
41. Yehia BR, Schranz AJ, Momplaisir FM, et al. Outcomes of HIV-infected patients receiving care at multiple clinics. AIDS Behav 2014; 18: 1511-22.